A fully human antibody showed promise against aggressive prostate cancer in preclinical testing. For most men diagnosed with prostate cancer, the disease grows slowly. The danger changes sharply when cancer cells begin to leave the prostate and spread to the…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.